• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖/水解胶原蛋白相互作用产物的微粒用于治疗呼吸道感染的研究进展

Development of chitosan/hydrolyzed collagen interaction product-based microparticles for the treatment of respiratory tract infections.

作者信息

Perucchini Mariasofia, Vigani Barbara, Ruggeri Marco, Pellegrini Angelica, Pietrocola Giampiero, Varacca Giada, Bettini Ruggero, Milanese Chiara, Sandri Giuseppina, Rossi Silvia

机构信息

Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.

Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.

出版信息

Int J Biol Macromol. 2025 Feb;288:138674. doi: 10.1016/j.ijbiomac.2024.138674. Epub 2024 Dec 11.

DOI:10.1016/j.ijbiomac.2024.138674
PMID:39672427
Abstract

Respiratory tract infections (RTIs) represent a significant global health issue, particularly for vulnerable population, such as children, the elderly, or patients with immunosuppression. In this context, the aim of the present work was the development of Chitosan/Hydrolyzed Collagen-based microparticles (Mps) as a pulmonary drug delivery system (PDDS) for the treatment of RTIs. Mps were produced via spray-drying and composed of chitosan (Cs), one of the most widely used polysaccharides in PDDS, and hydrolyzed collagen (HC), another promising material for the development of PDDS that has not yet been fully explored. The formation of an interaction product between Cs and HC occurred during the spray-drying process and was confirmed by infrared spectroscopy and thermal analysis. Mps were characterized in terms of morphology, particle size, zeta potential, aerodynamic performance, swelling behavior and biodegradation profile in simulated lung fluid. Mps biocompatibility was also assessed on adenocarcinomic human alveolar basal epithelial (A549) cells. Finally, Mps were characterized in vitro for antibacterial properties and their ability to inhibit bacterial adhesion to S. aureus and P. aeruginosa. An enhanced antibacterial effect was observed for Mps with respect to the pristine materials (Cs and HC) and their physical mixture. Moreover, Mps were also able to inhibit bacteria adhesion to epithelial cells.

摘要

呼吸道感染(RTIs)是一个重大的全球健康问题,尤其对于弱势群体,如儿童、老年人或免疫抑制患者。在此背景下,本研究的目的是开发基于壳聚糖/水解胶原蛋白的微粒(Mps)作为用于治疗呼吸道感染的肺部给药系统(PDDS)。Mps通过喷雾干燥制备,由壳聚糖(Cs)和水解胶原蛋白(HC)组成,壳聚糖是PDDS中使用最广泛的多糖之一,而水解胶原蛋白是一种尚未得到充分探索的、开发PDDS的有前景的材料。Cs和HC之间相互作用产物的形成发生在喷雾干燥过程中,并通过红外光谱和热分析得到证实。对Mps的形态、粒径、zeta电位、空气动力学性能、溶胀行为以及在模拟肺液中的生物降解特性进行了表征。还在人肺泡基底上皮腺癌(A549)细胞上评估了Mps的生物相容性。最后,对Mps的抗菌性能及其抑制细菌黏附金黄色葡萄球菌和铜绿假单胞菌的能力进行了体外表征。与原始材料(Cs和HC)及其物理混合物相比,观察到Mps具有增强的抗菌效果。此外,Mps还能够抑制细菌黏附上皮细胞。

相似文献

1
Development of chitosan/hydrolyzed collagen interaction product-based microparticles for the treatment of respiratory tract infections.基于壳聚糖/水解胶原蛋白相互作用产物的微粒用于治疗呼吸道感染的研究进展
Int J Biol Macromol. 2025 Feb;288:138674. doi: 10.1016/j.ijbiomac.2024.138674. Epub 2024 Dec 11.
2
Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.载多利培南微球的制备及特性研究。
J Aerosol Med Pulm Drug Deliv. 2018 Dec;31(6):347-357. doi: 10.1089/jamp.2017.1378. Epub 2018 Jun 7.
3
Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity.喷雾干燥可吸入环丙沙星粉末,改善气溶胶化和抗菌活性。
Int J Pharm. 2013 Jun 5;449(1-2):44-58. doi: 10.1016/j.ijpharm.2013.04.009. Epub 2013 Apr 12.
4
Synthesis of chitosan-alginate microspheres with high antimicrobial and antibiofilm activity against multi-drug resistant microbial pathogens.壳聚糖-海藻酸钠微球的合成及其对多药耐药微生物病原体的高抗菌和抗生物膜活性。
Microb Pathog. 2018 Jan;114:17-24. doi: 10.1016/j.micpath.2017.11.011. Epub 2017 Nov 11.
5
In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.载环丙沙星壳聚糖微球的体外抗菌活性及其对人肺上皮细胞的影响。
Int J Pharm. 2019 Oct 5;569:118578. doi: 10.1016/j.ijpharm.2019.118578. Epub 2019 Jul 27.
6
Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.通过替代加工方法制备的用于万古霉素结肠靶向递送的壳聚糖基微米和纳米颗粒。
Eur J Pharm Biopharm. 2015 May;92:112-9. doi: 10.1016/j.ejpb.2015.03.004. Epub 2015 Mar 11.
7
Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation.载药纳米凝胶-壳聚糖复合微球肺部递药用于吸入给药
J Aerosol Med Pulm Drug Deliv. 2019 Apr;32(2):78-87. doi: 10.1089/jamp.2018.1460. Epub 2018 Dec 8.
8
Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy.用于吸入气雾剂治疗的载左氧氟沙星交联壳聚糖微球的优化
Eur J Pharm Biopharm. 2015 Oct;96:65-75. doi: 10.1016/j.ejpb.2015.07.010. Epub 2015 Jul 17.
9
Dual cross-linked chitosan microspheres formulated with spray-drying technique for the sustained release of levofloxacin.采用喷雾干燥技术制备双交联壳聚糖微球用于左氧氟沙星的缓释。
Drug Dev Ind Pharm. 2019 Apr;45(4):568-576. doi: 10.1080/03639045.2019.1569025. Epub 2019 Jan 31.
10
Drying Using Supercritical Fluid Technology as a Potential Method for Preparation of Chitosan Aerogel Microparticles.使用超临界流体技术干燥作为制备壳聚糖气凝胶微粒的潜在方法
AAPS PharmSciTech. 2015 Dec;16(6):1235-44. doi: 10.1208/s12249-015-0312-2. Epub 2015 Mar 12.

引用本文的文献

1
Collagen-Chitosan Composites Enhanced with Hydroxytyrosol for Prospective Wound Healing Uses.用羟基酪醇增强的胶原蛋白-壳聚糖复合材料用于预期的伤口愈合用途。
Pharmaceutics. 2025 May 6;17(5):618. doi: 10.3390/pharmaceutics17050618.
2
Fabrication of N-acetylcysteine-loaded chitosan-cloaked polyphenol nanoparticles for treatment of pediatric pneumonia and acute lung injury.负载N-乙酰半胱氨酸的壳聚糖包覆多酚纳米颗粒的制备及其用于治疗小儿肺炎和急性肺损伤的研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 17. doi: 10.1007/s00210-025-04037-7.